These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A role for cathepsin E in the processing of mast-cell carboxypeptidase A. Henningsson F; Yamamoto K; Saftig P; Reinheckel T; Peters C; Knight SD; Pejler G J Cell Sci; 2005 May; 118(Pt 9):2035-42. PubMed ID: 15860733 [TBL] [Abstract][Full Text] [Related]
10. Serglycin: the master of the mast cell. Rönnberg E; Pejler G Methods Mol Biol; 2012; 836():201-17. PubMed ID: 22252637 [TBL] [Abstract][Full Text] [Related]
11. A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule-mediated pathway. Melo FR; Waern I; Rönnberg E; Åbrink M; Lee DM; Schlenner SM; Feyerabend TB; Rodewald HR; Turk B; Wernersson S; Pejler G J Biol Chem; 2011 Feb; 286(7):5423-33. PubMed ID: 21123167 [TBL] [Abstract][Full Text] [Related]
12. Mediators of human mast cells and human mast cell subsets. Schwartz LB Ann Allergy; 1987 Apr; 58(4):226-35. PubMed ID: 3105366 [TBL] [Abstract][Full Text] [Related]
13. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells. Razin E; Mencia-Huerta JM; Stevens RL; Lewis RA; Liu FT; Corey E; Austen KF J Exp Med; 1983 Jan; 157(1):189-201. PubMed ID: 6184439 [TBL] [Abstract][Full Text] [Related]
14. Mast cell mediators with emphasis on intestinal mast cells. Metcalfe DD Ann Allergy; 1984 Dec; 53(6 Pt 2):563-75. PubMed ID: 6095703 [TBL] [Abstract][Full Text] [Related]
15. Novel Strategies to Target Mast Cells in Disease. Paivandy A; Pejler G J Innate Immun; 2021; 13(3):131-147. PubMed ID: 33582673 [TBL] [Abstract][Full Text] [Related]
16. Mast cell mediators in allergic inflammation and mastocytosis. Castells M Immunol Allergy Clin North Am; 2006 Aug; 26(3):465-85. PubMed ID: 16931289 [TBL] [Abstract][Full Text] [Related]
17. Reduction with dithiothreitol causes serglycin-specific defects in secretory granule integrity of bone marrow derived mast cells. Braga T; Ringvall M; Tveit H; Abrink M; Pejler G Mol Immunol; 2009 Jan; 46(3):422-8. PubMed ID: 19059647 [TBL] [Abstract][Full Text] [Related]
18. A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components. Henningsson F; Hergeth S; Cortelius R; Abrink M; Pejler G FEBS J; 2006 Nov; 273(21):4901-12. PubMed ID: 17010166 [TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal mast cells in health and disease. Part I. Lemanske RF; Atkins FM; Metcalfe DD J Pediatr; 1983 Aug; 103(2):177-84. PubMed ID: 6410032 [TBL] [Abstract][Full Text] [Related]
20. Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Puri N; Roche PA Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2580-5. PubMed ID: 18250339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]